Bill Miller’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-272,000
Closed -$4.72M 43
2023
Q3
$4.72M Buy
272,000
+50,000
+23% +$1.04M 2.97% 16
2023
Q2
$4.62M Sell
222,000
-8,000
-3% -$174K 3.04% 16
2023
Q1
$5.41M Hold
230,000
0.34% 45
2022
Q4
$6.42M Buy
230,000
+25,000
+12% +$639K 0.41% 43
2022
Q3
$4.8M Sell
205,000
-10,000
-5% -$302K 0.29% 45
2022
Q2
$7.26M Buy
215,000
+35,000
+19% +$1.23M 0.37% 42
2022
Q1
$6.29M Hold
180,000
0.2% 52
2021
Q4
$5.48M Buy
180,000
+25,000
+16% +$814K 0.15% 57
2021
Q3
$5.08M Buy
+155,000
New +$4.96M 0.12% 58

Other funds holding OGN

Bill Miller's OGN Position: Q4 2023 in Review

Bill Miller sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 272,000 shares — an estimated $4.72M sold.

Bill Miller first reported a position in OGN in Q3 2021 and held it in 9 quarters. The position peaked at $7.26M in Q2 2022. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Bill Miller reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Bill Miller sold 272,000 Organon & Co shares in Q4 2023, an estimated $4.72M.
  • Bill Miller first reported a position in Organon & Co in Q3 2021 and held it in 9 quarters.
  • Bill Miller's Organon & Co position peaked at $7.26M in Q2 2022.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Miller Value Partners's 13F filing for Q4 2023, filed 14 Feb 2024.